Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 7Apidra
02 1Others Diabetes
Main Therapeutic Indication : Diabetes
Currency : USD
2019 Revenue in Millions : 375
2018 Revenue in Millions : 389
Growth (%) : -4
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 402
2019 Revenue in Millions : 416
Growth (%) : -3
Main Therapeutic Indication : Diabetes
Currency : USD
2014 Revenue in Millions : 16.70%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 966
2020 Revenue in Millions : 362
Growth (%) : 164
Main Therapeutic Indication : Diabetes
Currency : USD
2015 Revenue in Millions : 370
2014 Revenue in Millions : 414
Growth (%) : 12%
Main Therapeutic Indication : Diabetes
Currency : USD
2016 Revenue in Millions : 389
2015 Revenue in Millions : 399
Growth (%) : -2
Main Therapeutic Indication : Diabetes
Currency : USD
2017 Revenue in Millions : 467
2016 Revenue in Millions : 455
Growth (%) : 3
Main Therapeutic Indication : Diabetes
Currency : USD
2018 Revenue in Millions : 403
2017 Revenue in Millions : 426
Growth (%) : -5%
LOOKING FOR A SUPPLIER?